University of Kansas Medical Center Interstitial Lung Disease Research Unit (ILDRU) Biobank

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)

• The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.

• The participant is ≥ 18 years of age.

• The participant has signed an approved consent for this study (living patients only)

Locations
United States
Kansas
The University of Kansas Medical Center
RECRUITING
Kansas City
Contact Information
Primary
Kimberly Donnelly, Ph.D.
kdonnelly@kumc.edu
913-588-6067
Time Frame
Start Date: 2021-08-09
Estimated Completion Date: 2032-03-01
Participants
Target number of participants: 1000
Authors
Kristy Delaney, Chase Hall
Sponsors
Leads: University of Kansas Medical Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials